CoChat
Sign Up
Cited by 235

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Urinary biomarkers of oxidative status

Il'yasova, Dora, Scarbrough, Peter, Spasojevic, Ivan·2012·Clinica Chimica Acta
DOI 10.1016/j.cca.2012.06.012PMC PMC3424057
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cca.2012.06.012

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 145

  1. Block, 2006, Intraindividual variability of plasma antioxidants, markers of oxidative stress, C-reactive protein, cotinine, and other biomarkers, Epidemiology, 17, 404, 10.1097/01.ede.0000220655.53323.e9 · DOI
  2. Lacy, 2000, Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity, Hypertension, 36, 878, 10.1161/01.HYP.36.5.878 · DOI
  3. Zalba, 2005, NADPH oxidase-mediated oxidative stress: genetic studies of the p22phox gene in hypertension, Antioxid Redox Signal, 7, 1327, 10.1089/ars.2005.7.1327 · DOI
  4. Hussain, 2007, Inflammation and cancer: an ancient link with novel potentials, Int J Cancer, 121, 2373, 10.1002/ijc.23173 · DOI
  5. Tamura, 2006, Evaluation of a urinary multi-parameter biomarker set for oxidative stress in children, adolescents and young adults, Free Radic Res, 40, 1198, 10.1080/10715760600895191 · DOI
  6. Pryor, 1986, Oxy-radicals and related species: their formation, lifetimes, and reactions, Annu Rev Physiol, 48, 657, 10.1146/annurev.ph.48.030186.003301 · DOI
  7. Kadiiska, 2000, Biomarkers of oxidative stress study: are plasma antioxidants markers of CCl(4) poisoning?, Free Radic Biol Med, 28, 838, 10.1016/S0891-5849(00)00198-2 · DOI
  8. Kadiiska, 2005, Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?, Free Radic Biol Med, 38, 698, 10.1016/j.freeradbiomed.2004.09.017 · DOI
  9. Kadiiska, 2005, Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning, Free Radic Biol Med, 38, 711, 10.1016/j.freeradbiomed.2004.10.024 · DOI
  10. Kadiiska, 2011, Biomarkers of oxidative stress study IV: ozone exposure of rats and its effect on antioxidants in plasma and bronchoalveolar lavage fluid, Free Radic Biol Med, 51, 1636, 10.1016/j.freeradbiomed.2011.07.013 · DOI
  11. Il'yasova, 2009, Markers of oxidative status in a clinical model of oxidative assault: a pilot study in human blood following doxorubicin administration, Biomarkers, 14, 321, 10.1080/13547500902946757 · DOI
  12. Il'yasova, 2010, Urinary biomarkers of oxidative status in a clinical model of oxidative assault, Cancer Epidemiol Biomarkers Prev, 19, 1506, 10.1158/1055-9965.EPI-10-0211 · DOI
  13. Rajagopalan, 1988, Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity, Cancer Res, 48, 4766
  14. Gianni, 1985, Characterization of the cycle of iron-mediated electron transfer from Adriamycin to molecular oxygen, J Biol Chem, 260, 6820, 10.1016/S0021-9258(18)88854-8 · DOI
  15. Morrow, 1990, A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism, PNAS, 87, 9383, 10.1073/pnas.87.23.9383 · DOI
  16. Roberts, 2000, Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo, Free Radic Biol Med, 28, 505, 10.1016/S0891-5849(99)00264-6 · DOI
  17. Taber, 1997, A nomenclature system for the isoprostanes, Prostaglandins, 53, 63, 10.1016/S0090-6980(97)00005-1 · DOI
  18. Rokach, 1997, Nomenclature of isoprostanes: a proposal, Prostaglandins, 54, 853, 10.1016/S0090-6980(97)00184-6 · DOI
  19. Basu, 2008, F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications, Antioxid Redox Signal, 10, 1405, 10.1089/ars.2007.1956 · DOI
  20. Il'yasova, 2012, Urinary F2-isoprostanes as a biomarker of reduced risk of type 2 diabetes, Diabetes Care, 35, 173, 10.2337/dc11-1502 · DOI
  21. Morrow, 2000, The isoprostanes: their quantification as an index of oxidant stress status in vivo, Drug Metab Rev, 32, 377, 10.1081/DMR-100102340 · DOI
  22. Morrow, 2002, The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease, Am J Respir Crit Care Med, 166, S25, 10.1164/rccm.2206011 · DOI
  23. Richelle, 1999, Urinary isoprostane excretion is not confounded by the lipid content of the diet, FEBS Lett, 459, 259, 10.1016/S0014-5793(99)01259-4 · DOI
  24. Gopaul, 2000, Measurement of plasma F2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet, Free Radic Res, 33, 115, 10.1080/10715760000300671 · DOI
  25. Gopaul, 2000, Evaluation of the postprandial effects of a fast-food meal on human plasma F(2)-isoprostane levels, Free Radic Biol Med, 28, 806, 10.1016/S0891-5849(00)00167-2 · DOI
  26. Wu, 2010, Intra-person variation of urinary biomarkers of oxidative stress and inflammation, Cancer Epidemiol Biomarkers Prev, 19, 947, 10.1158/1055-9965.EPI-10-0046 · DOI
  27. Zhang, 2010, Quantification of the oxidative damage biomarker 2,3-dinor-8-isoprostaglandin-F(2alpha) in human urine using liquid chromatography–tandem mass spectrometry, Anal Biochem, 399, 302, 10.1016/j.ab.2009.12.024 · DOI
  28. Il'yasova, 2011, Urinary F2-isoprostanes, obesity, and weight gain in the IRAS cohort, Obesity (Silver Spring)
  29. Nourooz-Zadeh, 2008, Key issues in F2-isoprostane analysis, Biochem Soc Trans, 36, 1060, 10.1042/BST0361060 · DOI
  30. Il'yasova, 2004, Epidemiological marker for oxidant status: comparison of the ELISA and the gas chromatography/mass spectrometry assay for urine 2,3-dinor-5,6-dihydro-15-F2t-isoprostane, Ann Epidemiol, 14, 793, 10.1016/j.annepidem.2004.03.003 · DOI
  31. Davies, 2006, Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry, Anal Biochem, 348, 185, 10.1016/j.ab.2005.10.012 · DOI
  32. Morrow, 1999, Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress, Methods Enzymol, 300, 3, 10.1016/S0076-6879(99)00106-8 · DOI
  33. Mas, 2010, Measurement of urinary F(2)-isoprostanes by gas chromatography–mass spectrometry is confounded by interfering substances, Free Radic Res, 44, 191, 10.3109/10715760903390838 · DOI
  34. Base, 2010, Quantification of selected F2-isoprostanes and creatinine in human urine by liquid chromatography–electrospray tandem mass spectrometry (LC-ESI-MS/MS), Free Radic Biol Med, 49, S162, 10.1016/j.freeradbiomed.2010.10.455 · DOI
  35. Dorjgochoo, 2011, Obesity, age and oxidative stress in middle-aged and older women, Antioxid Redox Signal, 14, 2453, 10.1089/ars.2010.3337 · DOI
  36. Jones, 2011, Effects of aerobic training on oxidative status in postsurgical non-small cell lung cancer patients: a pilot study, Lung Cancer, 72, 45, 10.1016/j.lungcan.2010.08.002 · DOI
  37. Halliwell, 2010, Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues, Antioxid Redox Signal, 13, 145, 10.1089/ars.2009.2934 · DOI
  38. Stafforini, 2006, Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases, J Biol Chem, 281, 4616, 10.1074/jbc.M507340200 · DOI
  39. Epplein, 2009, Association of plasma micronutrient levels and urinary isoprostane with risk of lung cancer: the multiethnic cohort study, Cancer Epidemiol Biomarkers Prev, 18, 1962, 10.1158/1055-9965.EPI-09-0003 · DOI
  40. Gill, 2009, Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort, Cancer Causes Control, 20, 1161, 10.1007/s10552-009-9304-4 · DOI
  41. Dai, 2009, Oxidative stress, obesity, and breast cancer risk: results from the Shanghai Women's Health Study, J Clin Oncol, 27, 2482, 10.1200/JCO.2008.19.7970 · DOI
  42. Kanaya, 2011, F2-isoprostanes and adiposity in older adults, Obesity (Silver Spring), 19, 861, 10.1038/oby.2010.243 · DOI
  43. Guichardant, 2011, Functional lipidomics of oxidized products from polyunsaturated fatty acids, Chem Phys Lipids, 164, 544, 10.1016/j.chemphyslip.2011.05.002 · DOI
  44. Griffiths, 2002, Biomarkers, Mol Aspects Med, 23, 101, 10.1016/S0098-2997(02)00017-1 · DOI
  45. Janero, 1990, Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury, Free Radic Biol Med, 9, 515, 10.1016/0891-5849(90)90131-2 · DOI
  46. Li, 1994, An improved method for the measurement of malondialdehyde in biological samples, Lipids, 29, 73, 10.1007/BF02537094 · DOI
  47. Grotto, 2007, Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography–visible detection, J Pharm Biomed Anal, 43, 619, 10.1016/j.jpba.2006.07.030 · DOI · Paper page
  48. Draper, 1984, Urinary malondialdehyde as an indicator of lipid peroxidation in the diet and in the tissues, Lipids, 19, 836, 10.1007/BF02534512 · DOI
  49. Giera, 2011, Mild and selective labeling of malondialdehyde with 2-aminoacridone: assessment of urinary malondialdehyde levels, Analyst, 136, 2763, 10.1039/c1an15254h · DOI
  50. Syslova, 2009, Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silica-induced lung diseases, J Chromatogr B Analyt Technol Biomed Life Sci, 877, 2477, 10.1016/j.jchromb.2009.06.008 · DOI
  51. Korchazhkina, 2003, Measurement by reversed-phase high-performance liquid chromatography of malondialdehyde in normal human urine following derivatisation with 2,4-dinitrophenylhydrazine, J Chromatogr B Analyt Technol Biomed Life Sci, 794, 353, 10.1016/S1570-0232(03)00495-1 · DOI
  52. Hecker, 1987, Products, kinetics, and substrate specificity of homogeneous thromboxane synthase from human platelets: development of a novel enzyme assay, Arch Biochem Biophys, 254, 124, 10.1016/0003-9861(87)90088-9 · DOI
  53. Plastaras, 2000, Xenobiotic-metabolizing cytochromes P450 convert prostaglandin endoperoxide to hydroxyheptadecatrienoic acid and the mutagen, malondialdehyde, J Biol Chem, 275, 11784, 10.1074/jbc.275.16.11784 · DOI
  54. Brown, 1995, Urinary malondialdehyde-equivalents during ingestion of meat cooked at high or low temperatures, Lipids, 30, 1053, 10.1007/BF02536291 · DOI
  55. Chen, 1992, Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination, Biochem J, 288, 249, 10.1042/bj2880249 · DOI
  56. Xu, 2005, Induction of phase I, II and III drug metabolism/transport by xenobiotics, Arch Pharm Res, 28, 249, 10.1007/BF02977789 · DOI
  57. Balogh, 2011, Interactions of glutathione transferases with 4-hydroxynonenal, Drug Metab Rev, 43, 165, 10.3109/03602532.2011.558092 · DOI
  58. Forman, 2010, Reactive oxygen species and alpha, beta-unsaturated aldehydes as second messengers in signal transduction, Ann N Y Acad Sci, 1203, 35, 10.1111/j.1749-6632.2010.05551.x · DOI
  59. Strange, 1999, The glutathione S-transferases: influence of polymorphism on cancer susceptibility, IARC Sci Publ, 231
  60. Gueraud, 2006, Enzyme immunoassay for a urinary metabolite of 4-hydroxynonenal as a marker of lipid peroxidation, Free Radic Biol Med, 40, 54, 10.1016/j.freeradbiomed.2005.08.011 · DOI
  61. Alary, 1998, Identification of novel urinary metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in rats, Chem Res Toxicol, 11, 1368, 10.1021/tx980068g · DOI
  62. Alary, 1998, 1,4-Dihydroxynonene mercapturic acid, the major end metabolite of exogenous 4-hydroxy-2-nonenal, is a physiological component of rat and human urine, Chem Res Toxicol, 11, 130, 10.1021/tx970139w · DOI
  63. Alary, 1995, Mercapturic acid conjugates as urinary end metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in the rat, Chem Res Toxicol, 8, 34, 10.1021/tx00043a004 · DOI
  64. Peiro, 2005, Dihydroxynonene mercapturic acid, a urinary metabolite of 4-hydroxynonenal, as a biomarker of lipid peroxidation, Biofactors, 24, 89, 10.1002/biof.5520240110 · DOI
  65. Gasc, 2007, 4-hydroxynonenal in foodstuffs: heme concentration, fatty acid composition and freeze-drying are determining factors, Redox Rep, 12, 40, 10.1179/135100007X162257 · DOI
  66. Kuiper, 2010, Quantitation of mercapturic acid conjugates of 4-hydroxy-2-nonenal and 4-oxo-2-nonenal metabolites in a smoking cessation study, Free Radic Biol Med, 48, 65, 10.1016/j.freeradbiomed.2009.10.025 · DOI
  67. Furuhata, 2002, Thiolation of protein-bound carcinogenic aldehyde. An electrophilic acrolein-lysine adduct that covalently binds to thiols, J Biol Chem, 277, 27919, 10.1074/jbc.M202794200 · DOI
  68. Schaur, 2003, Basic aspects of the biochemical reactivity of 4-hydroxynonenal, Mol Aspects Med, 24, 149, 10.1016/S0098-2997(03)00009-8 · DOI
  69. Uchida, 2003, Histidine and lysine as targets of oxidative modification, Amino Acids, 25, 249, 10.1007/s00726-003-0015-y · DOI
  70. Nadkarni, 1995, Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal, Chem Res Toxicol, 8, 284, 10.1021/tx00044a014 · DOI
  71. Uchida, 1993, Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes, Proc Natl Acad Sci U S A, 90, 8742, 10.1073/pnas.90.18.8742 · DOI
  72. Houglum, 1997, Excess iron induces hepatic oxidative stress and transforming growth factor beta1 in genetic hemochromatosis, Hepatology, 26, 605, 10.1002/hep.510260311 · DOI
  73. Uchida, 1998, Protein-bound acrolein: potential markers for oxidative stress, Proc Natl Acad Sci, 95, 4882, 10.1073/pnas.95.9.4882 · DOI
  74. Furuhata, 2003, N-¦-(3-Methylpyridinium)lysine, a major antigenic adduct generated in acrolein-modified protein, J Biol Chem, 278, 48658, 10.1074/jbc.M309401200 · DOI
  75. Moore, 1998, Measurement of lipid peroxidation, Free Radic Res, 28, 659, 10.3109/10715769809065821 · DOI
  76. Piche, 1988, Identification of N-epsilon-(2-propenal)lysine as the main form of malondialdehyde in food digesta, Carcinogenesis, 9, 473, 10.1093/carcin/9.3.473 · DOI
  77. Daimon, 2003, Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes, Endocr J, 50, 61, 10.1507/endocrj.50.61 · DOI
  78. Tsukahara, 2003, Oxidative stress and altered antioxidant defenses in children with acute exacerbation of atopic dermatitis, Life Sci, 72, 2509, 10.1016/S0024-3205(03)00145-0 · DOI
  79. Calingasan, 1999, Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease, J Neurochem, 72, 751, 10.1046/j.1471-4159.1999.0720751.x · DOI
  80. Malencik, 2003, Dityrosine as a product of oxidative stress and fluorescent probe, Amino Acids, 25, 233, 10.1007/s00726-003-0014-z · DOI
  81. Giulivi, 2003, Tyrosine oxidation products: analysis and biological relevance, Amino Acids, 25, 227, 10.1007/s00726-003-0013-0 · DOI
  82. Heinecke, 1993, Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages, J Biol Chem, 268, 4069, 10.1016/S0021-9258(18)53581-X · DOI
  83. Heinecke, 2002, Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress, Free Radic Biol Med, 32, 1090, 10.1016/S0891-5849(02)00792-X · DOI
  84. Leeuwenburgh, 1999, Hydroxyl radical generation during exercise increases mitochondrial protein oxidation and levels of urinary dityrosine, Free Radic Biol Med, 27, 186, 10.1016/S0891-5849(99)00071-4 · DOI
  85. van der Vliet, 1994, Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite. Evidence for hydroxyl radical production from peroxynitrite, FEBS Lett, 339, 89, 10.1016/0014-5793(94)80391-9 · DOI
  86. Bhattacharjee, 2001, NADPH oxidase of neutrophils elevates o,o′-dityrosine cross-links in proteins and urine during inflammation, Arch Biochem Biophys, 395, 69, 10.1006/abbi.2001.2557 · DOI
  87. Giulivi, 1994, Dityrosine: a marker for oxidatively modified proteins and selective proteolysis, Methods Enzymol, 233, 363, 10.1016/S0076-6879(94)33042-5 · DOI
  88. DiMarco, 2007, Current analytical methods for the detection of dityrosine, a biomarker of oxidative stress, in biological samples, Mass Spectrom Rev, 26, 108, 10.1002/mas.20109 · DOI
  89. Chien, 2004, Ascorbate supplement reduces oxidative stress in dyslipidemic patients undergoing apheresis, Arterioscler Thromb Vasc Biol, 24, 1111, 10.1161/01.ATV.0000127620.12310.89 · DOI
  90. Orhan, 2004, Evaluation of a multi-parameter biomarker set for oxidative damage in man: increased urinary excretion of lipid, protein and DNA oxidation products after one hour of exercise, Free Radic Res, 38, 1269, 10.1080/10715760400013763 · DOI
  91. Manary, 2000, Increased oxidative stress in kwashiorkor, J Pediatr, 137, 421, 10.1067/mpd.2000.107512 · DOI
  92. Jordan, 2006, Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome, J Neural Transm, 113, 239, 10.1007/s00702-005-0316-2 · DOI
  93. Wells-Knecht, 1996, New biomarkers of Maillard reaction damage to proteins, Nephrol Dial Transplant, 11, 41, 10.1093/ndt/11.supp5.41 · DOI
  94. Maillard, 1912, The action of amino acids on sugar; the formation of melanoidin by a methodic route, C R Acad Sci, 154, 66
  95. Baynes, 1989, The Amadori product on protein: structure and reactions, Prog Clin Biol Res, 304, 43
  96. Dyer, 1991, Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo, J Biol Chem, 266, 11654, 10.1016/S0021-9258(18)99007-1 · DOI
  97. Wadman, 1975, N-epsilon-(carboxymethyl)lysine, a constituent of human urine, Clin Chim Acta, 59, 313, 10.1016/0009-8981(75)90007-8 · DOI
  98. Takahashi, 1993, The Maillard protein cross-link pentosidine in urine from diabetic patients, Diabetologia, 36, 664, 10.1007/BF00404078 · DOI
  99. Saxena, 2000, Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products, Invest Ophthalmol Vis Sci, 41, 1473
  100. Wautier, 2001, Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE, Am J Physiol Endocrinol Metab, 280, E685, 10.1152/ajpendo.2001.280.5.E685 · DOI
  101. Lal, 2002, Role of oxidative stress in advanced glycation end product-induced mesangial cell activation, Kidney Int, 61, 2006, 10.1046/j.1523-1755.2002.00367.x · DOI
  102. Macaione, 2007, RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy, Acta Neurol Scand, 115, 115, 10.1111/j.1600-0404.2006.00724.x · DOI
  103. Lin, 2009, RAGE signaling in inflammation and arterial aging, Front Biosci, 14, 1403, 10.2741/3315 · DOI
  104. Brownlee, 1981, The biochemistry of the complications of diabetes mellitus, Annu Rev Biochem, 50, 385, 10.1146/annurev.bi.50.070181.002125 · DOI
  105. Brownlee, 1988, Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications, N Engl J Med, 318, 1315, 10.1056/NEJM198805193182007 · DOI
  106. Mendez, 2010, Trends in advanced glycation end products research in diabetes mellitus and its complications, Mol Cell Biochem, 341, 33, 10.1007/s11010-010-0434-5 · DOI
  107. Grote, 2012, The Associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case–control study within the prospective EPIC cohort, Cancer Epidemiol Biomarkers Prev, 21, 619, 10.1158/1055-9965.EPI-11-1139 · DOI
  108. Bartling, 2011, Prognostic potential and tumor growth-inhibiting effect of plasma advanced glycation end products in non-small cell lung carcinoma, Mol Med, 17, 980, 10.2119/molmed.2011.00085 · DOI
  109. Barlovic, 2011, RAGE biology, atherosclerosis and diabetes, Clin Sci (Lond), 121, 43, 10.1042/CS20100501 · DOI
  110. Rahmadi, 2011, Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease, Clin Chem Lab Med, 49, 385, 10.1515/CCLM.2011.079 · DOI
  111. Cadet, 2012, Biologically relevant oxidants and terminology, classification and nomenclature of oxidatively generated damage to nucleobases and 2-deoxyribose in nucleic acids, Free Radic Res, 46, 367, 10.3109/10715762.2012.659248 · DOI
  112. Cooke, 2009, A commentary on “Urea, the most abundant component in urine, cross-reacts with a commercial 8-OH-dG ELISA kit and contributes to overestimation of urinary 8-OH-dG”. What is ELISA detecting?, Free Radic Biol Med, 47, 30, 10.1016/j.freeradbiomed.2009.04.003 · DOI
  113. Cooke, 2008, Measurement and meaning of oxidatively modified DNA lesions in urine, Cancer Epidemiol Biomarkers Prev, 17, 3, 10.1158/1055-9965.EPI-07-0751 · DOI
  114. Gallo, 2008, Validation of biomarkers for the study of environmental carcinogens: a review, Biomarkers, 13, 505, 10.1080/13547500802054611 · DOI
  115. Sampath, 2012, Regulation of DNA glycosylases and their role in limiting disease, Free Radic Res, 46, 460, 10.3109/10715762.2012.655730 · DOI
  116. Gackowski, 2001, 8-Oxo-7,8-dihydroguanine and 8-oxo-7,8-dihydro-2′-deoxyguanosine levels in human urine do not depend on diet, Free Radic Res, 35, 825, 10.1080/10715760100301321 · DOI
  117. Cooke, 2005, DNA repair is responsible for the presence of oxidatively damaged DNA lesions in urine, Mutat Res, 574, 58, 10.1016/j.mrfmmm.2005.01.022 · DOI
  118. Loft, 2006, Prospective study of 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion and the risk of lung cancer, Carcinogenesis, 27, 1245, 10.1093/carcin/bgi313 · DOI
  119. Song, 2009, Urea, the most abundant component in urine, cross-reacts with a commercial 8-OH-dG ELISA kit and contributes to overestimation of urinary 8-OH-dG, Free Radic Biol Med, 47, 41, 10.1016/j.freeradbiomed.2009.02.017 · DOI
  120. Miwa, 2004, Quantitative determination of urinary 8-hydroxy-2′-deoxyguanosine level in healthy Japanese volunteers, Biofactors, 22, 249, 10.1002/biof.5520220150 · DOI
  121. Pilger, 2002, Urinary excretion of 8-hydroxy-2′-deoxyguanosine measured by high-performance liquid chromatography with electrochemical detection, J Chromatogr B Analyt Technol Biomed Life Sci, 778, 393, 10.1016/S0378-4347(01)00449-2 · DOI
  122. Sabatini, 2005, A method for routine quantitation of urinary 8-hydroxy-2′-deoxyguanosine based on solid-phase extraction and micro-high-performance liquid chromatography/electrospray ionization tandem mass spectrometry, Rapid Commun Mass Spectrom, 19, 147, 10.1002/rcm.1763 · DOI
  123. Pilger, 2001, Longitudinal study of urinary 8-hydroxy-2′-deoxyguanosine excretion in healthy adults, Free Radic Res, 35, 273, 10.1080/10715760100300811 · DOI
  124. Pilger, 2006, 8-Hydroxy-2′-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures, Int Arch Occup Environ Health, 80, 1, 10.1007/s00420-006-0106-7 · DOI
  125. Wilson, 2011, Variation in base excision repair capacity, Mutat Res, 711, 100, 10.1016/j.mrfmmm.2010.12.004 · DOI
  126. Jones, 2007, Exploration of methods to identify polymorphisms associated with variation in DNA repair capacity phenotypes, Mutat Res, 616, 213, 10.1016/j.mrfmmm.2006.11.005 · DOI
  127. Shen, 2006, Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer, Cancer Epidemiol Biomarkers Prev, 15, 1614, 10.1158/1055-9965.EPI-06-0218 · DOI
  128. Gackowski, 2003, Products of oxidative DNA damage and repair as possible biomarkers of susceptibility to lung cancer, Cancer Res, 63, 4899
  129. Paz-Elizur, 2007, Development of an enzymatic DNA repair assay for molecular epidemiology studies: distribution of OGG activity in healthy individuals, DNA Repair (Amst), 6, 45, 10.1016/j.dnarep.2006.08.003 · DOI
  130. Kaur, 1990, Action of biologically-relevant oxidizing species upon uric acid. Identification of uric acid oxidation products, Chem Biol Interact, 73, 235, 10.1016/0009-2797(90)90006-9 · DOI
  131. Grootveld, 1987, Measurement of allantoin and uric-acid in human-body fluids — a potential index of free-radical reactions in vivo, Biochem J, 243, 803, 10.1042/bj2430803 · DOI
  132. Wu, 1989, Urate oxidase: primary structure and evolutionary implications, PNAS, 86, 9412, 10.1073/pnas.86.23.9412 · DOI
  133. Ames, 1981, Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis, Proc Natl Acad Sci U S A, 78, 6858, 10.1073/pnas.78.11.6858 · DOI
  134. Kand'ar, 2006, Monitoring of antioxidant properties of uric acid in humans for a consideration measuring of levels of allantoin in plasma by liquid chromatography, Clin Chim Acta, 365, 249, 10.1016/j.cca.2005.09.002 · DOI
  135. Tolun, 2010, Allantoin in human urine quantified by ultra-performance liquid chromatography–tandem mass spectrometry, Anal Biochem, 402, 191, 10.1016/j.ab.2010.03.033 · DOI
  136. Young, 1942, On the estimation of allantoin by the Rimini–Schryver reaction, J Biol Chem, 142, 839, 10.1016/S0021-9258(18)45082-X · DOI
  137. Kim, 2009, Simultaneous determination of uric acid metabolites allantoin, 6-aminouracil, and triuret in human urine using liquid chromatography–mass spectrometry, J Chromatogr B Analyt Technol Biomed Life Sci, 877, 65, 10.1016/j.jchromb.2008.11.029 · DOI
  138. Benzie, 1999, Simultaneous measurement of allantoin and urate in plasma: analytical evaluation and potential clinical application in oxidant:antioxidant balance studies, Clin Chem, 45, 901, 10.1093/clinchem/45.6.901 · DOI
  139. Ma, 2005, A study of the effect of oral glucose loading on plasma oxidant:antioxidant balance in normal subjects, Eur J Nutr, 44, 250, 10.1007/s00394-004-0518-7 · DOI
  140. Hellsten, 2001, Allantoin formation and urate and glutathione exchange in human muscle during submaximal exercise, Free Radic Biol Med, 31, 1313, 10.1016/S0891-5849(01)00631-1 · DOI
  141. Tam, 2005, Effects of vitamins C and e on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study, J Rheumatol, 32, 275
  142. Berthemy, 1999, Quantitative determination of an extremely polar compound allantoin in human urine by LC-MS/MS based on the separation on a polymeric amino column, J Pharm Biomed Anal, 19, 429, 10.1016/S0731-7085(98)00200-3 · DOI
  143. Il'yasova, 2011, Individual responses to chemotherapy-induced oxidative stress, Breast Cancer Res Treat, 125, 583, 10.1007/s10549-010-1158-7 · DOI
  144. Mikami, 2000, Is allantoin in serum and urine a useful indicator of exercise-induced oxidative stress in humans?, Free Radic Res, 32, 235, 10.1080/10715760000300241 · DOI
  145. Gruber, 2009, Allantoin in human plasma, serum, and nasal-lining fluids as a biomarker of oxidative stress: avoiding artifacts and establishing real in vivo concentrations, Antioxid Redox Signal, 11, 1767, 10.1089/ars.2008.2364 · DOI

Cited by

Sorted by citations

See all 235

Metadata

Authors
Il'yasova, D., Scarbrough, P., & Spasojevic, I.
Venue
Clinica Chimica Acta
Publisher
Elsevier BV
Published
2012-10
Volume
413
Issue
19-20
Pages
1446-1453
ISSN
0009-8981
DOI
10.1016/j.cca.2012.06.012
PMC
PMC3424057
Cited by
235
References
6
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
National Institutes of Health (5P50CA108786, 1R01DK081028, 5R25-CA126938-02)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Urinary biomarkers of oxidative status. https://app.cochat.ai/papers/10.1016/j.cca.2012.06.012
The paper
Il'yasova, D., Scarbrough, P., & Spasojevic, I. (2012). Urinary biomarkers of oxidative status. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2012.06.012